Finance

Lists
Why is 8AT down 2.07%?
Dive Deeper
8AT:FRA
Aclaris Therapeutics Inc
€4.63
-2.07%
(-0.098) 1D
Sep 30, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 8AT...
Open
€4.63
High
€4.63
Low
€4.63
Mkt. cap
774.27M
Avg. vol.
78.00
Volume
0.00
52-wk high
€5.55
52-wk low
€1.55
No. of employees
71
Open
€4.63
High
€4.63
Low
€4.63
Mkt. cap
774.27M
Avg. vol.
78.00
Volume
0.00
52-wk high
€5.55
52-wk low
€1.55
No. of employees
71
About Aclaris Therapeutics Inc
CEO-
Employees71
Founded2012
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.30M
1.30M
2.00M
1.63M
Cost of goods sold
15.48M
18.05M
17.44M
19.52M
Cost of revenue
15.48M
18.05M
17.44M
19.52M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.87M
5.58M
6.74M
6.05M
Operating expense
4.87M
5.58M
6.74M
6.05M
Total operating expenses
20.35M
23.63M
24.19M
25.57M
Operating income
-17.05M
-22.33M
-22.19M
-23.94M
Other non operating income
716.00K
1.30M
854.00K
972.00K
EBT including unusual items
-14.61M
-19.80M
-19.82M
-21.50M
EBT excluding unusual items
-14.51M
-19.40M
-19.82M
-21.20M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-14.61M
-19.80M
-19.82M
-21.50M
Net profit margin
-442.98%
-1,528.57%
-993.19%
-1,320.13%
Earnings per share
-0.12
-0.16
-0.15
-0.15
Interest and investment income
1.82M
1.63M
1.51M
1.76M
Interest expense
-
-
-
-
Net interest expenses
1.82M
1.63M
1.51M
1.76M
Depreciation and amortization charges
-
-
-
-
EBITDA
-17.04M
-22.32M
-22.19M
-23.94M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps